Weight loss is not enough to treat dyslipidemia in women

Published Date: 06 Mar 2023

Obesity continues to exist around the world despite the risk to health and death from illness and disease.

Read Full News

Latest News

Gaps Exist in Cardiometabolic Risk Factor Treatment for CKM

Management of cardiometabolic risk factors for cardiovascular-kidney-metabolic syndrome falls short, particularly for younger adults, who have the lowest treatment rates.

Roosevelt’s Public Image and Overlooked Illness

A 2023 review reexamines Yalta through a medical lens, showing how Roosevelt’s deteriorating cardiovascular status may have been underestimated.

FDA Okays Drug to Curb Pancreatitis in Hypertriglyceridemia

The expanded indication makes olezarsen the first therapy approved to reduce the acute pancreatitis risk in adults with severe hypertriglyceridemia.

Statin Initiation Tied to Lower Frailty Risk in Older Adults

Starting statins is associated with a reduced risk for frailty in older adults, including those with prefrailty at baseline.

Synthetic Cannabinoids in Teens: What Clinicians Should Know

French authorities urge clinicians to consider synthetic cannabinoid exposure in adolescents presenting with unexplained neurologic, psychiatric, or cardiovascular symptoms.

Why Does the Heart Rarely Develop Cancer?

New findings suggest the heart’s mechanical activity actively restrains tumor growth, revealing a pathway that could inspire future cancer treatments.

Todays Updates

Europe Must Rethink Medicine Pricing or Risk Losing Investment

Europe will need to rethink how it values and pays for innovative ⁠medicines or risk losing manufacturing investments and clinical trials, the head of Europe's pharmaceutical industry lobby said.

Medicare AI Creates Errors and Delays for Patients, Doctors

Patients, doctors, and other healthcare professionals who spoke with KFF Health News say the effort has created confusion, errors, long wait times, and stress.

Is Creatine for Brain Health Worth a Try?

Research on creatine supplementation has moved from the gym to the brain lab, leading neurologist Heidi Moawad to review the data on creatine’s potential for improving cognitive health.

S1 Episode 2: Is Alcohol the Missing Piece in Your MASLD Workup?

Patients with MASLD often underreport alcohol use and even modest intake can block improvement. Drs VanWagner and Ajmera share practical tools to quantify intake, spot MetALD, and counsel patients effectively.

S1 Episode 1: Can Primary Care Catch MASLD Before Cirrhosis?

MASLD is a silent condition and labs may look normal. Drs VanWagner and Shubrook walk through who to screen, how to use FIB-4, and when primary care can manage MASLD without a specialist.

Palbociclib Gains HER2+ Breast Cancer Maintenance Indication

Palbociclib is now the first CDK4/6 inhibitor approved for metastatic disease regardless of HER2 status.

Mirvetuximab Fails to Boost Survival in Platinum-Eligible OC

Mirvetuximab has come up short in the first randomized trial testing an antibody-drug conjugate plus standard carboplatin for patients with platinum-sensitive ovarian cancer.

Todays Updates

Europe Must Rethink Medicine Pricing or Risk Losing Investment

Europe will need to rethink how it values and pays for innovative ⁠medicines or risk losing manufacturing investments and clinical trials, the head of Europe's pharmaceutical industry lobby said.

Medicare AI Creates Errors and Delays for Patients, Doctors

Patients, doctors, and other healthcare professionals who spoke with KFF Health News say the effort has created confusion, errors, long wait times, and stress.

Is Creatine for Brain Health Worth a Try?

Research on creatine supplementation has moved from the gym to the brain lab, leading neurologist Heidi Moawad to review the data on creatine’s potential for improving cognitive health.

S1 Episode 2: Is Alcohol the Missing Piece in Your MASLD Workup?

Patients with MASLD often underreport alcohol use and even modest intake can block improvement. Drs VanWagner and Ajmera share practical tools to quantify intake, spot MetALD, and counsel patients effectively.

S1 Episode 1: Can Primary Care Catch MASLD Before Cirrhosis?

MASLD is a silent condition and labs may look normal. Drs VanWagner and Shubrook walk through who to screen, how to use FIB-4, and when primary care can manage MASLD without a specialist.

Palbociclib Gains HER2+ Breast Cancer Maintenance Indication

Palbociclib is now the first CDK4/6 inhibitor approved for metastatic disease regardless of HER2 status.

Mirvetuximab Fails to Boost Survival in Platinum-Eligible OC

Mirvetuximab has come up short in the first randomized trial testing an antibody-drug conjugate plus standard carboplatin for patients with platinum-sensitive ovarian cancer.

Latest News

Management of cardiometabolic risk factors for cardiovascular-kidney-metabolic syndrome falls short, particularly for younger adults, who have the lowest treatment rates.

A 2023 review reexamines Yalta through a medical lens, showing how Roosevelt’s deteriorating cardiovascular status may have been underestimated.

The expanded indication makes olezarsen the first therapy approved to reduce the acute pancreatitis risk in adults with severe hypertriglyceridemia.

Starting statins is associated with a reduced risk for frailty in older adults, including those with prefrailty at baseline.

French authorities urge clinicians to consider synthetic cannabinoid exposure in adolescents presenting with unexplained neurologic, psychiatric, or cardiovascular symptoms.

New findings suggest the heart’s mechanical activity actively restrains tumor growth, revealing a pathway that could inspire future cancer treatments.

News All Time

AI's 'Blind Trust' Problem Puts Patients at Risk

Panelists at HLTH Europe 2026 warned that clinicians and patients are increasingly deferring to algorithmic outputs over independent judgment.

Closing the Women's Health Gap With AI and Better Data

From cardiac misdiagnosis to an 8-year wait for endometriosis, experts at HLTH Europe lay out how AI and multimodal data can start closing the gender health gap.

Protein and Creatine Supplements Are No Longer Niche

The fitness supplements have gone mainstream. How much is too much? How should GLP-1 patients use them? Will creatine save our brains? Here’s what the science says.

GLP-1s Tied to Higher Risk for Dizziness, Fainting for Some

Hypotension-related events increased after starting GLP-1s in patients taking multiple antihypertensive medications.

Phase 3 HCM Drug Offers Promising Results in Exercise Tests

Treatment with aficamten may improve multiple measures of exercise in patients with obstructive hypertrophic cardiomyopathy, a study finds.

How Extreme Heat Threatens Athlete Safety

High temperatures, humidity, and prolonged exertion can overwhelm the body’s cooling systems. Here’s what clinicians should know about heat risk in sport.

GLP-1 Therapy: Can a Myostatin Antibody Preserve Muscle?

A phase 2 trial suggests myostatin inhibition may reduce lean body mass loss during tirzepatide treatment while maintaining overall weight reduction.

Will Genomics Move From Innovation to Routine Care?

Pharmacogenomics and polygenic risk scores could replace trial-and-error prescribing — but workflow, trust, and equity stand in the way.

Early Pregnancy Thyroid Issues Signal Later Hypothyroidism

Thyroid abnormalities in early pregnancy are associated with an increased risk of developing hypothyroidism later in life.

Europe’s Liver Crisis Is Hidden in Plain Sight

Alcohol, ultraprocessed food, and undetected hepatitis are fueling a quiet liver crisis across Europe; researchers say earlier action could prevent millions of premature deaths.

Shorter Romosozumab Course Works as Well as 12-Month Regimen

A 3-month course of romosozumab followed by denosumab produced bone density gains comparable to those of the standard 12-month regimen in postmenopausal women at high fracture risk.

Early Weight Loss in T2D Tied to Fewer Vascular Events

Achieving at least 15% weight loss within 2 years of a T2D diagnosis is linked to lower risks for macrovascular and microvascular complications than maintaining a stable weight.

Hypotension Emerges as Top CVD Factor Linked to AD

Among multiple cardiovascular disease subtypes examined in two large cohorts, hypotension shows the strongest association with Alzheimer’s disease.

QFR-Guided PCI Linked to Improved Long-Term Outcomes

Patients undergoing quantitative flow ratio-guided PCI had fewer major adverse cardiac events over 5 years than those treated with angiography-guided PCI.

5 Critical Mistakes Doctors Make in Managing CKM

As cardiovascular-kidney-metabolic syndrome becomes increasingly adopted, physicians are faced with the challenge of overcoming old, siloed habits.

Treatment Timing May Affect Serum Urate Control in Gout

In patients with gout, the late initiation of urate-lowering therapy is linked to poorer long-term serum urate control, and better treatment adherence is linked to improved control.

Recommended News For You

WHO launches plan for free child cancer medicines

Study: Pre-operative THP leads to pCR in 64% of early-stage HER2+ ER- breast cancer patients

Obesity-associated cancers may be on the rise in Puerto Rico

First-Line HCC Trial's Lenvatinib-Pembrolizumab Combo Misses Target.

Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients

Adding cell-based vaccine to liver cancer therapy can slow cancer progression

Do I qualify for a cancer clinical trial?

Recommended Articles For You

Exosomes in Cancer: A Novel Frontier for Therapy and Biomarker Discovery 

A New Hope: Exploring the Potential of Pegaspargase in Treating Cancer 

Contemporary Frameworks in Oncology Across Clinical Settings 

Understanding Colon Cancer: Symptoms, Causes, and Treatment Options  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Worse Outcomes After Esophagectomy at Private Equity-Owned Hospitals

2.

Adding Daratumumab to VRd Boosts MRD Negativity in Transplant-Ineligible Myeloma

3.

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

4.

Prostate cancer relapse after radiotherapy is strongly predicted by biological markers.

5.

Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer

1.

Giant Sebaceous Cyst of the Scalp Mimicking a Soft Tissue Tumor: A Case Study

2.

Refining AML Survival: Prognostic Factors, Therapies, and Stem Cell Strategies Reviewed

3.

ADCs and Bispecific Antibodies: Advancing the Future of Cancer Immunotherapy

4.

Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care

5.

Revolutionizing Thyroid Cancer: Advances in Molecular Genetics and Personalized Treatment Approaches

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Current Scenario of Cancer- Palliative Care to Close the Care Gap

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III

5.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot